Connect your AI

Stereotaxis STXS Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

AbbottABT

——

MedtronicMDT

——

ITG

Integer HoldingsITGR

——

iRadimedIRMD

——

Intuitive SurgicalISRG

——

IAR

Integra LifeSciencesIART

——

Other financials

Income statement

Revenue$6.3M-15.8%

Gross profit$3.8M-6.6%

Operating income-$6.0M-0.9%

Net income-$5.9M-0.7%

EPS (diluted)-$0.06+14.3%

Balance sheet

Cash & equivalents$14.6M+36.7%

Total debt$5.3M-10.0%

Total equity$14.4M+399%

Total assets$54.0M+18.2%

Cash flow

Operating cash flow-$3.4M-93.5%

CapEx$79.0K—

Free cash flow-$3.5M—

Valuation

Market cap$168.11M-11.6%

Enterprise value$158.77M-15.9%

P/S5.4×-0.6×

Profitability

Gross margin53.9%+0.5pp

Operating margin-71%-14.0pp

Net margin-69.5%-13.7pp

FCF margin-35.5%-2.4pp

Returns & leverage

Return on equity-251.5%-29.9pp

Debt / equity0.4×-1.7×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Stereotaxis's remainder of fiscal year 2024?: Stereotaxis (STXS) reported remainder of fiscal year 2024 of $822K in Q1 2026.
How has Stereotaxis's remainder of fiscal year 2024 changed year-over-year?: Stereotaxis's remainder of fiscal year 2024 increased by 1.6% year-over-year, from $809K to $822K.